exchang
protein
directli
activ
camp
epac
critic
campdepend
signal
pathway
mediat
discoveri
epac
protein
significantli
facilit
understand
campdepend
signal
pathway
effort
along
line
open
new
avenu
develop
novel
therapeut
cancer
diabet
heart
failur
inflamm
infect
neurolog
disord
human
diseas
past
decad
import
progress
made
identif
epac
agonist
antagonist
biolog
pharmacolog
applic
review
briefli
summar
recent
report
novel
function
epac
discoveri
small
molecul
modul
challeng
futur
perspect
also
discuss
express
develop
matur
human
tissu
multidomain
protein
three
isoform
kda
molecular
weight
enrich
nervou
system
endocrin
tissu
protein
consider
similar
structur
sequenc
similar
human
consist
two
region
ntermin
regulatori
region
ctermin
catalyt
region
regulatori
region
epac
protein
includ
dishevel
pleckstrin
dep
domain
cyclic
nucleotid
bind
domain
cnbd
ctermin
catalyt
region
compos
three
basic
domain
name
cell
divis
cycl
homolog
gef
domain
ra
associ
ra
domain
ra
exchang
motif
rem
domain
absenc
camp
activ
epac
autoinhibit
ntermin
regulatori
region
ctermin
catalyt
region
epac
held
togeth
intramolecular
interact
therebi
prevent
rap
bind
epac
keep
epac
inact
fig
cell
stimul
extracellular
signal
ac
activ
variou
ligand
bind
gproteincoupl
receptor
gpcr
promot
convers
atp
camp
bind
camp
cnbd
allow
regulatori
region
rotat
leav
enough
space
rap
bind
consequ
activ
epac
catalyz
exchang
guanosin
diphosph
gdp
guanosin
triphosph
gtp
control
rapmedi
biolog
function
fig
epac
signal
pathway
play
critic
role
variou
biolog
respons
includ
insulin
secret
neuron
function
cardiovascular
function
vascular
function
inflamm
cancer
pain
infect
epac
signal
pathway
involv
insulin
secret
pancreat
b
cell
promot
glucosestimul
insulin
secret
gsi
regul
intracellular
ca
concentr
date
three
pathway
reveal
insulin
secret
first
activ
phospholipas
ce
plce
protein
kinas
c
pkc
ryanodin
receptor
ryr
sarcoendoplasm
reticulum
ca
atpas
serca
second
directli
interact
sulfonylurea
receptor
lead
atpsensit
potassium
channel
k
atp
closur
respons
increas
atpadp
ratio
thu
regul
intracellular
ca
level
third
interact
munc
piccolo
potenti
rapid
ca
depend
exocytosi
accord
recent
studi
may
also
play
import
role
gsi
knockout
mous
model
show
decreas
express
glucos
transport
transcript
factor
collect
studi
suggest
epac
repres
potenti
therapeut
target
diabet
obes
interact
import
role
regul
neurotransmitt
releas
addit
recent
knockout
mice
model
studi
provid
vivo
evid
promot
transmitt
releas
maintain
readili
releas
pool
rrp
mossi
fiber
mf
synaps
hippocampu
grow
evid
demonstr
epac
particip
neurit
growth
neuron
differenti
cell
necessari
mediat
growth
arrest
neurit
extens
neuron
differenti
mitogen
activ
protein
kinas
mapk
pathway
includ
extracellular
signalregul
kinas
erk
studi
base
knockout
mous
model
reveal
epac
protein
exert
signific
physiolog
role
learn
memori
social
interact
brain
furthermor
mice
show
reduc
dendrit
spine
motil
densiti
cortic
neuron
display
defect
social
interact
ultrason
vocal
thu
target
epac
signal
pathway
may
present
novel
strategi
treatment
cn
diseas
heart
epac
enhanc
cardiac
contractil
regul
intracellular
ca
concentr
plce
pkc
ryr
ca
calmodulindepend
protein
kinas
ii
camkii
signal
pathway
hypertroph
heart
epac
mainli
found
overexpress
suggest
epac
may
play
import
role
cardiac
hypertrophi
activ
epac
prevent
h
induc
product
reactiv
oxygen
radic
inhibit
activ
apoptosi
cardiomyocyt
recent
report
activ
b
adrenerg
receptor
b
ar
could
lead
sarcoplasm
reticulum
sr
ca
leak
arrhythmia
phosphoryl
camkiid
pka
note
distribut
mice
myocyt
significantli
differ
limit
nuclear
signal
found
gather
around
tubul
indic
involv
arrhythmogen
sr
ca
leak
epac
also
play
critic
role
develop
cardiac
fibrosi
import
involv
epac
cardiovascular
function
offer
new
direct
discoveri
new
treatment
cardiovascular
diseas
role
epac
vascular
function
involv
regul
smooth
muscl
cell
migrat
prolifer
vascular
tone
endotheli
barrier
eb
function
inflamm
smooth
muscl
cell
epac
enhanc
smooth
muscl
cell
migrat
process
vascular
remodel
neointim
format
respons
femor
arteri
mechan
injur
evid
support
epac
enhanc
smooth
muscl
cell
migrat
induc
integrin
activ
regul
extracellular
matrix
compon
scretion
besid
epac
induc
vasorelax
vasoconstrict
distinct
regul
intracellular
ca
concentr
k
atp
vivo
studi
reveal
knockout
gene
attenu
neointima
format
inhibit
smooth
muscl
cell
migrat
meantim
ca
concentr
cofilinmedi
lamellipodia
format
decreas
recent
cheng
cowork
found
involv
neointima
format
akt
signal
pathway
mitochondri
fission
respons
vascular
injuri
mous
carotid
arteri
ligat
model
therefor
epac
promis
therapeut
target
vascular
diseas
addit
epac
exhibit
antiinflammatori
activ
interleukin
receptor
signal
upregul
express
suppressor
cytokin
signal
vec
vitro
vivo
studi
reveal
inhibit
epac
led
express
vascular
cell
adhes
molecul
decreas
mediat
effect
phosphodiesteras
activ
find
indic
signal
pathway
may
provid
novel
mean
treatment
vascular
inflamm
inclus
atherosclerosi
instent
restenosi
moreov
recent
hyperalgesia
prime
epac
knockout
mous
model
studi
uncov
key
role
chronic
inflammatori
pain
control
phosphoryl
mediat
gpcr
kinas
worth
mention
epac
also
associ
airway
diseas
via
modul
airway
smooth
muscl
cell
function
taken
togeth
epac
emerg
therapeut
target
drug
discoveri
cardiovascular
diseas
inflamm
airway
diseas
studi
focus
function
role
cancer
prolifer
apoptosi
migrat
recent
report
epacerk
akt
signal
pathway
promot
b
cell
antigen
receptor
bcr
mediat
growth
arrest
apoptosi
b
lymphoma
cell
line
human
glioblastoma
cell
line
pka
pathway
mediat
cell
death
cell
cycl
arrest
process
rolipram
regul
glioblastoma
cell
densiti
prostat
cancer
cell
increas
cell
prolifer
surviv
involv
rasmapk
signal
pathway
epac
thu
crucial
regul
cell
migrat
prolifer
numer
paper
support
promot
variou
cancer
cell
includ
cervic
fibrosarcoma
melanoma
ovarian
pancreat
prostat
migrat
metastasi
campmedi
immun
function
well
document
breakthrough
work
implic
epac
anticanc
immunotherapi
report
recent
identifi
play
essenti
role
regul
tcellmedi
immunosuppress
interestingli
result
recent
studi
suggest
epac
signal
pathway
may
upregul
aerob
glycolysi
promot
oncogenesi
studi
demonstr
emerg
target
cancer
therapi
camp
signal
control
wide
rang
process
pathogen
bacteria
fungi
protozoa
camp
critic
mediat
microbi
pathogen
infecti
virul
gene
express
well
known
function
camp
mainli
regul
epac
pka
thu
surpris
epac
shown
play
critic
role
bacteri
infect
exampl
accord
recent
genet
manipul
pharmacolog
approach
vivo
knockout
gene
inhibit
activ
prevent
bacteri
adhes
invas
fatal
rickettsios
result
offer
new
avenu
fight
bacteri
infect
display
novel
mode
action
hostpathogen
interact
small
molecul
target
epac
protein
given
essenti
role
epac
variou
biolog
function
human
diseas
tremend
effort
devot
discov
small
molecul
epac
modul
pharmacolog
probe
potenti
drug
candid
treatment
human
diseas
base
differ
chemic
structur
current
report
epac
modul
divid
two
major
categori
camp
analogu
noncycl
nucleotid
small
molecul
natur
camp
analogu
epac
modul
subclass
often
exhibit
epac
agonist
activ
noncycl
nucleotid
ligand
tend
act
epac
antagonist
epac
inhibitor
camp
analogu
epac
modul
earlier
effort
discoveri
develop
epac
modul
mainli
focus
design
synthesi
analogu
compound
camp
fig
none
analogu
exhibit
select
epac
pka
limit
usag
studi
order
investig
differ
biolog
function
epac
pka
develop
epac
specif
modul
imper
breakthrough
epac
select
modul
made
bo
cowork
comparison
bind
site
compound
epac
pka
camp
domain
found
oh
group
compound
could
form
hydrogen
bond
highli
conserv
glutam
residu
human
pka
protein
pka
camp
domain
absent
epac
camp
bind
site
fig
interact
oh
group
conserv
glutam
residu
essenti
camp
bind
pka
camp
domain
modif
oh
group
could
lead
select
eapc
modul
base
find
seri
oalkylmodifi
analogu
compound
exampl
compound
omecamp
fig
design
exhibit
epacpka
select
worth
mention
replac
oh
group
hydrogen
led
compound
deoxycamp
fig
compound
show
epacpka
select
dramat
loss
epac
activ
activ
compar
compound
modif
compound
led
compound
omecamp
aka
fig
potent
halfmaxim
activ
mm
select
epacpka
select
epac
agonist
sinc
discoveri
compound
wide
use
power
tool
elucid
epac
function
rat
model
inject
compound
provok
mechan
hyperalgesia
mechan
activ
e
isoform
pkc
threshold
subthreshold
concentr
compound
remark
increas
frequenc
ca
oscil
human
peripher
blood
lymphocyt
pbl
cultur
treat
compound
mm
level
decreas
approxim
viral
replic
accord
recent
studi
compound
recapitul
cocaineinduc
increas
acid
receptor
ampar
dopamin
neuron
ventral
tegment
area
vta
indic
therapeut
potenti
drug
addit
base
aforement
advantag
compound
wide
employ
use
chemic
probe
epac
function
studi
biolog
applic
limit
due
poor
plasma
membran
penetr
capabl
esterif
neg
charg
singli
bond
oxygen
compound
phosphat
group
led
compound
omecampam
ak
fig
contain
mixtur
equatori
axial
isom
compound
work
prodrug
hydrolyz
releas
quickli
cross
plasma
membran
compound
display
effect
potent
compound
without
affect
epacpka
select
greatli
facilit
studi
epac
signal
pathway
howev
good
substrat
phosphodiesteras
pde
also
act
pde
inhibitor
hand
introduc
phenyl
group
compound
posit
led
compound
n
phenylcamp
fig
biolog
studi
suggest
compound
act
full
pka
agonist
instead
epac
agonist
find
indic
modif
posit
compound
may
lead
pkaepac
select
agonist
recent
sever
analogu
compound
epac
modul
report
exampl
compound
fig
highli
specif
epac
activ
better
lipophil
membran
permeabl
compound
nevertheless
still
suffer
pde
inhibit
side
effect
rehmann
cowork
develop
seri
compound
analogu
agonist
structureguid
approach
repres
compound
exhibit
activ
potenc
toward
although
camp
analogu
eg
compound
wide
use
power
chemic
probe
studi
epac
function
attent
paid
select
target
beyond
pka
epac
accord
recent
studi
camp
analogu
eg
compound
multipl
cellular
target
therebi
lead
crosstarget
activ
offtarget
effect
noncycl
nucleotid
small
molecul
epac
modul
seri
noncycl
nucleotid
epac
select
inhibitor
report
cheng
colleagu
establish
sensit
robust
fluorescencebas
high
throughput
ht
assay
screen
epac
specif
inhibitor
compet
compound
fig
compound
suitabl
screen
epac
specif
inhibitor
induc
fluoresc
chang
bind
purifi
fulllength
revers
addit
excess
camp
three
compound
nci
divers
set
librari
identifi
ic
valu
rang
mm
compet
compound
bind
furthermor
expand
screen
maybridg
hitfind
compound
librari
compound
seven
compound
compound
fig
discov
complet
inhibit
gef
activ
mm
presenc
concentr
camp
develop
novel
epac
inhibitor
zhou
cowork
optim
ht
hit
chemic
lead
modif
substitu
phenyl
ring
compound
compound
fig
identifi
potent
compound
seri
ic
valu
mm
dock
studi
reveal
size
posit
substitu
play
role
epac
inhibitori
activ
concentr
mm
compound
select
block
campinduc
epac
activ
inhibit
campmedi
pka
activ
cell
line
compound
complet
block
akt
phosphoryl
concentr
mm
start
ht
hit
zhou
cowork
conduct
structur
modif
afford
compound
fig
show
ic
mm
competit
bind
presenc
compound
compound
inhibitori
exchang
activ
alter
campinduc
type
ii
pka
holoenzym
activ
concentr
mm
result
suggest
compound
inhibitor
moreov
conclus
also
confirm
live
cell
imag
studi
use
pka
fret
sensor
replac
paratoluenesulfonyl
motif
compound
trifluoromethyl
anilin
group
led
compound
fig
compound
act
excel
specif
inhibitor
ic
valu
mm
competit
bind
compound
inhibit
campmedi
gef
activ
ic
mm
show
signific
inhibit
mm
identifi
noncycl
nucleotid
select
inhibitor
recent
studi
team
focus
compound
fig
compound
identifi
noncycl
nucleotid
ic
mm
ic
mm
dual
inhibitor
meantim
show
effect
pka
even
high
concentr
furthermor
involv
epacmedi
activ
akt
phosphoryl
pancreat
beta
cell
insulin
product
secret
although
previou
work
found
level
overexpress
human
pancreat
ductal
adenocarcinoma
pda
mechan
unclear
cheng
cowork
reveal
compound
inhibit
adhes
cell
without
affect
cell
prolifer
viabil
furthermor
orthotop
metastat
mous
model
inject
dose
mgkg
daili
week
compound
prevent
local
distant
mia
cell
spread
significantli
reduc
metastasi
liver
result
indic
promis
target
pancreat
cancer
migrat
invas
cronstein
cowork
reveal
compound
complet
block
ranklinduc
osteoclast
differenti
mm
might
diminish
bone
destruct
inflammatori
arthriti
vivo
compound
dosedepend
inhibit
freund
adjuv
cfa
induc
mechan
hyperalgesia
without
influenc
mechan
sensit
control
mice
suggest
compound
may
develop
potenti
therapi
chronic
pain
essenti
role
campmedi
signal
pathway
modul
leptin
productionsecretin
regul
metabol
homeostasi
previous
explor
import
epaccamp
pathway
leptin
resist
recent
discov
studi
investig
epaccamp
pathway
obes
regul
report
cheng
cowork
investig
impli
epac
inhibitor
compound
inhibit
leptin
product
secret
vitro
vivo
find
offer
strong
evid
could
act
novel
pharmacolog
target
diabet
obes
therapi
recent
tao
et
al
found
capac
compound
nontox
concentr
mm
protect
cell
merscov
sarscov
infect
via
inhibit
replic
viral
rna
express
merscov
sarscov
protein
without
affect
viru
bind
express
local
epac
protein
compar
wildtyp
mice
treat
compound
mgkg
daili
ip
day
group
control
group
surviv
rate
significantli
improv
rickettsia
australi
infect
mechan
compound
could
complet
block
rickettsi
attach
andor
invas
earli
step
monj
cowork
report
compound
could
regul
schwann
cell
prolifer
differenti
inhibit
epac
blood
stage
compound
prevent
plasmodium
falciparum
merozoit
invas
human
erythrocyt
inhibit
parasit
growth
blood
stage
moreov
compound
regul
reestablish
endotheli
recoveri
ec
barrier
function
thrombin
induc
hyperperm
addit
pk
studi
indic
display
excel
bioavail
pharmacolog
toxicolog
paramet
concern
initi
rais
compound
may
caus
epac
denatur
properti
fals
posit
address
issu
cheng
cowork
conduct
batteri
biochem
pharmacolog
character
compound
valid
compound
epac
specif
inhibitor
compound
wide
use
use
chemic
probe
elucid
role
epac
anticanc
migrat
antiinflamm
antiobes
antiviru
antibacteria
diseas
preliminari
structureact
relationship
sar
compound
reveal
choro
atom
phenyl
ring
essenti
epac
inhibitori
activ
replac
choro
atom
phenyl
ring
hydrogen
atom
led
compound
ic
mm
fig
activ
loss
inhibit
ad
anoth
cl
atom
compound
led
compound
fig
ic
valu
compound
ic
mm
improv
compar
compound
zhou
cowork
systemat
investig
sar
compound
alter
linker
modif
substitut
isoxazol
ring
result
dramat
activ
loss
howev
slightli
modif
phenyl
ring
addit
third
choro
atom
compound
afford
compound
fig
compound
prove
potent
compound
ic
valu
mm
inhibit
addit
also
show
high
inhibitori
effect
ic
valu
mm
molecular
dock
studi
show
compound
could
form
hydrophob
hydrogen
bond
interact
cbd
motif
isoxazol
ring
stretch
hydrophob
pocket
form
hydrophob
interact
residu
phenyl
moieti
occupi
interact
hydrophob
pocket
consist
moreov
crucial
hydrogen
bond
nh
linker
side
oxygen
atom
residu
meanwhil
courilleau
et
al
identifi
tetrahydroquinolin
deriv
name
essentiel
compound
librari
fig
epac
inhibitor
intact
cell
show
certain
inhibitori
activ
gef
without
affect
pka
activ
compound
report
exhibit
modest
select
versu
provid
select
inhibitor
earli
sar
studi
indic
substitu
tetrahydroquinolin
pharmacophor
requisit
inhibitori
activ
stereochemistri
also
play
import
role
inhibitori
activ
r
enantiom
found
potent
enantiom
gef
inhibit
vitro
addit
compound
exhibit
select
versu
compound
may
serv
use
chemic
probe
elucid
biolog
function
relev
studi
need
valid
targetspecif
therapeut
potenti
conclus
futur
perspect
almost
two
decad
sinc
discoveri
epac
import
regul
campmedi
biolog
function
process
major
advanc
made
understand
function
role
epac
aid
genet
knockout
pharmacolog
manipul
variou
pathogen
model
moreov
recent
find
reveal
critic
role
epac
manifest
divers
maladi
includ
cancer
diabet
obes
heart
failur
inflamm
pain
infect
cn
disord
suggest
epac
present
promis
target
treatment
variou
diseas
xray
cocryst
analysi
nmr
spectroscopi
provid
molecular
clue
epac
activ
also
give
research
clear
vision
bind
mode
epac
protein
modul
exampl
first
breakthrough
work
develop
epac
activ
compound
ration
design
facilit
cocryst
structur
analysi
compound
although
compound
prodrug
use
pharmacolog
tool
probe
campmedi
signal
big
challeng
exhibit
crosstarget
activ
offtarget
effect
thu
therapeut
applic
camp
analogu
epac
agonist
potenti
limit
anoth
mileston
field
de
novo
discoveri
specif
inhibitor
fluorescencebas
ht
assay
due
excel
epacpka
select
compound
wide
appli
use
chemic
probe
discrimin
epac
relat
signal
pathway
biolog
function
addit
compound
analogu
exert
excel
vivo
pk
toxic
profil
promis
lead
compound
therapeut
applic
nevertheless
extens
chemic
optim
imper
improv
potenc
ideal
submicromolar
nanomolar
ic
isoformselect
vs
class
epac
inhibitor
therefor
epacisoform
specif
agonist
antagonist
high
potenc
select
still
urgent
need
end
modern
drug
discoveri
approach
eg
ht
fragmentbas
drug
discoveri
computeraid
drug
design
may
pave
way
note
may
play
signific
distinct
biolog
role
varieti
human
diseas
especi
cancer
inflamm
cardiovascular
diseas
cn
disord
eg
drug
addict
pain
infect
diabet
henc
potent
epac
agonist
antagonist
high
select
well
ideal
pharmacokinet
profil
highli
appreci
clinic
develop
toward
viabl
therapeut
strategi
variou
human
diseas
